Recent Innovations in Medical and Surgical Retina

PurposeTo highlight recent innovations in the medical and surgical treatment of retinal disease. DesignRetrospective literature review. MethodsThe peer-reviewed, published (during 2012) English literature was searched using the Medline database. Articles deemed relevant were selected and highlighted. ResultsA number of important innovations in the treatment of retinal disease have occurred during the past year. We review developments in regenerative medicine (e.g., retinal prosthesis, optogenetics, cell-based therapy), diagnostics (e.g., swept source optical coherence tomography [OCT], intraoperative OCT, multimodal imaging), surgical innovations (e.g., chemical vitreolysis with ocriplasmin, 27-gauge vitrectomy), and pharmacological therapy of retinal vascular disease (e.g., use of ranibizumab and aflibercept in the treatment of macular edema associated with diabetic retinopathy and retinal vein occlusion). ConclusionsMany important innovations in regenerative medicine, diagnostic and surgical instrumentation, and pharmacological therapy for retinal vascular disease have occurred during the past year. In view of the number of agents in early phase clinical trials (e.g., treatments for dry age-related macular degeneration) as well as technologies under development (e.g., microrobots for vitreous surgery), this trend will continue.

[1]  Matthew R. Behrend,et al.  The Argus™ II retinal prosthesis: Factors affecting patient selection for implantation , 2013, Progress in Retinal and Eye Research.

[2]  Angelika Braun,et al.  Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS , 2013, Proceedings of the Royal Society B: Biological Sciences.

[3]  M. Zarbin.  The promise of stem cells for age-related macular degeneration and other retinal degenerative diseases , 2013 .

[4]  A. Tsujikawa,et al.  Three-dimensional tomographic features of dome-shaped macula by swept-source optical coherence tomography. , 2013, American journal of ophthalmology.

[5]  Sina Farsiu,et al.  Visualization of Real-Time Intraoperative Maneuvers with a Microscope-Mounted Spectral Domain Optical Coherence Tomography System , 2013, Retina.

[6]  L. Aiello,et al.  Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. , 2012, Ophthalmology.

[7]  A. Kampik,et al.  Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. , 2012, The New England journal of medicine.

[8]  Ursula Schmidt-Erfurth,et al.  One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. , 2012, Ophthalmology.

[9]  Gislin Dagnelie,et al.  Use of the Argus II retinal prosthesis to improve visual guidance of fine hand movements. , 2012, Investigative ophthalmology & visual science.

[10]  Dirk Trauner,et al.  Photochemical Restoration of Visual Responses in Blind Mice , 2012, Neuron.

[11]  E. Souied,et al.  Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration. , 2012, American journal of ophthalmology.

[12]  Lea Querques,et al.  Multimodal imaging of dry age‐related macular degeneration , 2012, Acta ophthalmologica.

[13]  K. Oiwa,et al.  Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy , 2012, Eye.

[14]  J. Haller,et al.  Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. , 2012, Ophthalmology.

[15]  Quan Dong Nguyen,et al.  Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. , 2012, Ophthalmology.

[16]  P. Campochiaro,et al.  Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. , 2012, Ophthalmology.

[17]  Jessy D. Dorn,et al.  Interim results from the international trial of Second Sight's visual prosthesis. , 2012, Ophthalmology.

[18]  Mark S Humayun,et al.  Assessment of MRI issues for the Argus II retinal prosthesis. , 2012, Magnetic resonance imaging.

[19]  S. Schwartz,et al.  Embryonic stem cell trials for macular degeneration: a preliminary report , 2012, The Lancet.

[20]  A. Russo,et al.  Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg , 2012, Case Reports in Ophthalmology.

[21]  Alice K. Cho,et al.  Retinal prostheses: current clinical results and future needs. , 2011, Ophthalmology.

[22]  Robin Ray,et al.  Intraoperative microscope-mounted spectral domain optical coherence tomography for evaluation of retinal anatomy during macular surgery. , 2011, Ophthalmology.

[23]  Sunil K Srivastava,et al.  Intraoperative spectral-domain optical coherence tomography during complex retinal detachment repair. , 2011, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[24]  Edward S Boyden,et al.  Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  A. Messias,et al.  INTRAVITREAL INJECTION OF AUTOLOGOUS BONE MARROW–DERIVED MONONUCLEAR CELLS FOR HEREDITARY RETINAL DYSTROPHY: A Phase I Trial , 2011, Retina.

[26]  D. Kurosaka,et al.  CHOROIDAL THICKNESS AND VISUAL ACUITY IN HIGHLY MYOPIC EYES , 2011, Retina.

[27]  Francesco Bandello,et al.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. , 2011, Ophthalmology.

[28]  Jennifer K. Sun,et al.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. , 2011, Ophthalmology.

[29]  W. Drexler,et al.  Three-dimensional 1060-nm OCT: choroidal thickness maps in normal subjects and improved posterior segment visualization in cataract patients. , 2010, Investigative ophthalmology & visual science.

[30]  Matthias Bolz,et al.  ANGIOGENIC AND INFLAMMATORY MARKERS IN THE INTRAOCULAR FLUID OF EYES WITH DIABETIC MACULAR EDEMA AND INFLUENCE OF THERAPY WITH BEVACIZUMAB , 2010, Retina.

[31]  Jessy D. Dorn,et al.  Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task , 2010, British Journal of Ophthalmology.

[32]  F. Fitzke,et al.  Localisation and significance of in vivo near-infrared autofluorescent signal in retinal imaging , 2010, British Journal of Ophthalmology.

[33]  M. Maia,et al.  Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture. , 2010, Current diabetes reviews.

[34]  Karl Deisseroth,et al.  Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa , 2010, Science.

[35]  Sarah Gray,et al.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[36]  Lloyd Paul Aiello,et al.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema , 2010, Ophthalmology.

[37]  P. Campochiaro,et al.  Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.

[38]  George A. Williams,et al.  Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. , 2010, Archives of ophthalmology.

[39]  E. Sugano,et al.  Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. , 2010, Experimental eye research.

[40]  C. Costagliola,et al.  Enhanced depth imaging spectral-domain optical coherence tomography. , 2010, Retina.

[41]  U. Kellner,et al.  FUNDUS AUTOFLUORESCENCE (488 NM) AND NEAR-INFRARED AUTOFLUORESCENCE (787 NM) VISUALIZE DIFFERENT RETINAL PIGMENT EPITHELIUM ALTERATIONS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION , 2010, Retina.

[42]  A. V. Cideciyan,et al.  Retinal pigment epithelium defects in humans and mice with mutations in MYO7A: imaging melanosome-specific autofluorescence. , 2009, Investigative ophthalmology & visual science.

[43]  Zhuo-Hua Pan,et al.  Ectopic Expression of Multiple Microbial Rhodopsins Restores ON and OFF Light Responses in Retinas with Photoreceptor Degeneration , 2009, The Journal of Neuroscience.

[44]  D Besch,et al.  Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients , 2008, British Journal of Ophthalmology.

[45]  B. Roska,et al.  Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration , 2008, Nature Neuroscience.

[46]  Herwig Baier,et al.  Remote Control of Neuronal Activity with a Light-Gated Glutamate Receptor , 2007, Neuron.

[47]  Edoardo Midena,et al.  Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration , 2007, British Journal of Ophthalmology.

[48]  H. Gerding,et al.  The Minimal Invasive Retina Implant (miRI) Project: Long-Term Angiographic and Histopathological Findings After Implantation of Devices Carrying Microelectrodes Penetrating the Sclera, Choroid and Retina , 2007 .

[49]  R. Hornig,et al.  Chronic Epiretinal Chip Implant in Blind Patients With Retinitis Pigmentosa: Long-Term Clinical Results , 2007 .

[50]  H. Gerding,et al.  Experimental implantation of epiretinal retina implants (EPI-RET) with an IOL-type receiver unit , 2007, Journal of neural engineering.

[51]  P. Campochiaro,et al.  Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. , 2006, American journal of ophthalmology.

[52]  F. Delori,et al.  Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. , 2006, Investigative ophthalmology & visual science.

[53]  A. Dizhoor,et al.  Ectopic Expression of a Microbial-Type Rhodopsin Restores Visual Responses in Mice with Photoreceptor Degeneration , 2006, Neuron.

[54]  Weng Tao,et al.  Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Kramer,et al.  Imaging light-modulated release of synaptic vesicles in the intact retina: Retinal physiology at the dawn of the post-electrode era , 2005, Vision Research.

[56]  C. Eckardt,et al.  TRANSCONJUNCTIVAL SUTURELESS 23-GAUGE VITRECTOMY , 2005, Retina.

[57]  E. Isacoff,et al.  Light-activated ion channels for remote control of neuronal firing , 2004, Nature Neuroscience.

[58]  A. Y. Chow,et al.  The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa. , 2004, Archives of ophthalmology.

[59]  A. Kampik,et al.  Posterior vitreous detachment induced by microplasmin. , 2004, Investigative ophthalmology & visual science.

[60]  R. Josephberg.  Sutureless virectomy surgery. , 2003, Ophthalmology.

[61]  S. Kelly,et al.  Perceptual efficacy of electrical stimulation of human retina with a microelectrode array during short-term surgical trials. , 2003, Investigative ophthalmology & visual science.

[62]  Zhongping Chen,et al.  Optimal wavelength for ultrahigh-resolution optical coherence tomography. , 2003, Optics express.

[63]  L. Halperin,et al.  OFFICE-BASED SUTURELESS TRANSCONJUNCTIVAL PARS PLANA VITRECTOMY , 2002, Retina.

[64]  T. Gardner,et al.  Diabetic retinopathy: more than meets the eye. , 2002, Survey of ophthalmology.

[65]  M. Trese,et al.  A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. , 2002, Ophthalmology.

[66]  J S Sunness,et al.  Measuring geographic atrophy in advanced age-related macular degeneration. , 1999, Investigative ophthalmology & visual science.

[67]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[68]  C K Dorey,et al.  In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. , 1995, Investigative ophthalmology & visual science.

[69]  R. Liversidge.  We are all in the gutter, but some of us are looking at the stars , 2012 .

[70]  T. Wachtler,et al.  Stimulation with a wireless intraocular epiretinal implant elicits visual percepts in blind humans. , 2011, Investigative ophthalmology & visual science.

[71]  Y. Tano,et al.  A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. , 2010, Ophthalmology.

[72]  E. Isacoff,et al.  Allosteric control of an ionotropic glutamate receptor with an optical switch , 2006, Nature chemical biology.

[73]  S. Kishi,et al.  Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. , 1999, Retina.

[74]  M. Humayun,et al.  Artificial vision , 1998, Eye.

[75]  Michael A. Singer.  EFFECT OF COMBINATION THERAPY WITH BEVACIZUMAB AND DEXAMETHASONE INTRAVITREAL IMPLANT IN PATIENTS WITH RETINAL VEIN OCCLUSION , 2022 .